Hemangioma surgery: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
(15 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Hemangioma}} | {{Hemangioma}} | ||
{{CMG}} | {{CMG}};{{AE}} {{NM}} | ||
==Overview== | ==Overview== | ||
Surgery is not the first-line treatment option for patients with hemangioma. It is usually reserved for patients with either massive protuberant proliferating hemangioma and lesions that are refractory to less invasive treatments. | |||
==Surgery== | |||
* Surgical management involves excision, laser treatment or both. <ref name="CallahanYoon2012">{{cite journal|last1=Callahan|first1=Alison B.|last2=Yoon|first2=Michael K.|title=Infantile hemangiomas: A review|journal=Saudi Journal of Ophthalmology|volume=26|issue=3|year=2012|pages=283–291|issn=13194534|doi=10.1016/j.sjopt.2012.05.004}}</ref><ref name="RichterFriedman2012">{{cite journal|last1=Richter|first1=Gresham T.|last2=Friedman|first2=Adva B.|title=Hemangiomas and Vascular Malformations: Current Theory and Management|journal=International Journal of Pediatrics|volume=2012|year=2012|pages=1–10|issn=1687-9740|doi=10.1155/2012/645678}}</ref> | |||
* Intralesional steroid treatment is also an option for focal hemangiomas such as: | |||
** Parotid | |||
** Nasal tip | |||
** Subglottis | |||
** Eyelid | |||
* Repeat therapy is often required, but systemic side effects are limited. | |||
* Excision is the appropriate for localized lesions the fibrofatty remnants (residuum) of involuted hemangiomas. | |||
* Elective subtotal excision of massive protuberant proliferating hemangiomas can be employed in order to maintain aesthetic facial boundaries. | |||
* Small remnants of disease are then left for involution. | |||
===Excision=== | |||
* Excision is the appropriate for localized lesions the fibrofatty remnants (residuum) of involuted hemangiomas. | |||
* Elective subtotal excision of massive protuberant proliferating hemangiomas can be employed in order to maintain aesthetic facial boundaries. | |||
* Small remnants of disease are then left for involution. | |||
==Phototherapy== | |||
===Pulsed dye laser=== | |||
Pulsed dye laser is considered to be effective choice for a series of skin disorders including superficial hemangiomas.<ref name="CaucanasPaquet2011">{{cite journal|last1=Caucanas|first1=Marie|last2=Paquet|first2=Philippe|last3=Henry|first3=Frédérique|last4=Piérard-Franchimont|first4=Claudine|last5=Reginster|first5=Marie-Annick|last6=Piérard|first6=Gérald E.|title=Intense Pulsed-Light Therapy for Proliferative Haemangiomas of Infancy|journal=Case Reports in Dermatological Medicine|volume=2011|year=2011|pages=1–5|issn=2090-6463|doi=10.1155/2011/253607}}</ref> | |||
* Residual erythema and telangiectasias frequently remain in involuted hemangiomas and are best treated by selective photothermolysis using the flash pulse dye laser (FPDL). | |||
* Ulcerative lesions during proliferation can be treated with FPDL to induce healing and new epidermal growth. | |||
===Intense pulsed light=== | |||
* IPL flash lamps emit broadband polychromatic high-intensity light in the wavelength spectrum ranging 515-1200nm.<ref name="CaucanasPaquet2011">{{cite journal|last1=Caucanas|first1=Marie|last2=Paquet|first2=Philippe|last3=Henry|first3=Frédérique|last4=Piérard-Franchimont|first4=Claudine|last5=Reginster|first5=Marie-Annick|last6=Piérard|first6=Gérald E.|title=Intense Pulsed-Light Therapy for Proliferative Haemangiomas of Infancy|journal=Case Reports in Dermatological Medicine|volume=2011|year=2011|pages=1–5|issn=2090-6463|doi=10.1155/2011/253607}}</ref> | |||
* They target vessels at various depths inside the skin. | |||
* The effect relies on selective photothermolysis. | |||
* The indication spectrum includes vascular tumors including hemangiomas. | |||
==References== | |||
{{Reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
{{ | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Cardiology]] | |||
[[Category:Needs overview]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medicine]] | |||
[[Category:Vascular medicine]] | |||
[[Category:Surgery]] |
Latest revision as of 22:01, 29 July 2020
Hemangioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hemangioma surgery On the Web |
American Roentgen Ray Society Images of Hemangioma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Surgery is not the first-line treatment option for patients with hemangioma. It is usually reserved for patients with either massive protuberant proliferating hemangioma and lesions that are refractory to less invasive treatments.
Surgery
- Surgical management involves excision, laser treatment or both. [1][2]
- Intralesional steroid treatment is also an option for focal hemangiomas such as:
- Parotid
- Nasal tip
- Subglottis
- Eyelid
- Repeat therapy is often required, but systemic side effects are limited.
- Excision is the appropriate for localized lesions the fibrofatty remnants (residuum) of involuted hemangiomas.
- Elective subtotal excision of massive protuberant proliferating hemangiomas can be employed in order to maintain aesthetic facial boundaries.
- Small remnants of disease are then left for involution.
Excision
- Excision is the appropriate for localized lesions the fibrofatty remnants (residuum) of involuted hemangiomas.
- Elective subtotal excision of massive protuberant proliferating hemangiomas can be employed in order to maintain aesthetic facial boundaries.
- Small remnants of disease are then left for involution.
Phototherapy
Pulsed dye laser
Pulsed dye laser is considered to be effective choice for a series of skin disorders including superficial hemangiomas.[3]
- Residual erythema and telangiectasias frequently remain in involuted hemangiomas and are best treated by selective photothermolysis using the flash pulse dye laser (FPDL).
- Ulcerative lesions during proliferation can be treated with FPDL to induce healing and new epidermal growth.
Intense pulsed light
- IPL flash lamps emit broadband polychromatic high-intensity light in the wavelength spectrum ranging 515-1200nm.[3]
- They target vessels at various depths inside the skin.
- The effect relies on selective photothermolysis.
- The indication spectrum includes vascular tumors including hemangiomas.
References
- ↑ Callahan, Alison B.; Yoon, Michael K. (2012). "Infantile hemangiomas: A review". Saudi Journal of Ophthalmology. 26 (3): 283–291. doi:10.1016/j.sjopt.2012.05.004. ISSN 1319-4534.
- ↑ Richter, Gresham T.; Friedman, Adva B. (2012). "Hemangiomas and Vascular Malformations: Current Theory and Management". International Journal of Pediatrics. 2012: 1–10. doi:10.1155/2012/645678. ISSN 1687-9740.
- ↑ 3.0 3.1 Caucanas, Marie; Paquet, Philippe; Henry, Frédérique; Piérard-Franchimont, Claudine; Reginster, Marie-Annick; Piérard, Gérald E. (2011). "Intense Pulsed-Light Therapy for Proliferative Haemangiomas of Infancy". Case Reports in Dermatological Medicine. 2011: 1–5. doi:10.1155/2011/253607. ISSN 2090-6463.